RxDoctor Payments Data

Alexander Jafari

Dermatology · Bellaire, TXNPI 1043892045

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 43.9% of the total. 2025 is the largest year on record at $9,088, more than ten times the $588 reported in 2023.

$10,437in general payments, 2019–2025

Across 96 payments — averaging $108.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$5K
  • Biogen$1K
  • AbbVie$792
  • UCB, Inc.$522
  • Incyte Corporation$502
  • Galderma Laboratories, L.p.$486
  • plus $2K from 14 others

What the payments were for

  • Travel & lodging$4,38642%
  • Food & beverage$5,91357%
  • Education$1381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,437 in reported general payments places this provider in the 70th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Other dermatology in Bellaire

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →